HighTower Advisors LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 13.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 313,300 shares of the pharmacy operator’s stock after selling 46,879 shares during the period. HighTower Advisors LLC’s holdings in CVS Health were worth $26,847,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Kilter Group LLC purchased a new position in shares of CVS Health during the 2nd quarter valued at $27,000. Beaird Harris Wealth Management LLC grew its stake in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares during the period. J.Safra Asset Management Corp purchased a new stake in CVS Health in the 2nd quarter worth about $30,000. Timbuktu Capital Management LLC purchased a new stake in CVS Health in the 2nd quarter worth about $31,000. Finally, Dunhill Financial LLC purchased a new stake in CVS Health in the 2nd quarter worth about $32,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.
Top CVS Health Stories
These are some of the CVS stories that stood out recently:
- Positive Sentiment: CVS ranked ninth on a recent “affordable blue chip stocks” list, which may reinforce its value-stock appeal, but the ranking itself is not a fundamental change to the business. Article: Why CVS Health cracked the Best Affordable Blue Chip Stocks list
- Neutral Sentiment: CVS also announced winners of a youth soccer contest, with grants for their nonprofit organizations. This is brand and community outreach rather than a material financial catalyst. Article: CVS Pharmacy names Home Team Heroes contest winners
- Negative Sentiment: A local pharmacist activist said the upcoming CVS split would not benefit patients or workers. This reflects criticism of the plan, but the report does not establish broader opposition or quantify any financial impact. Article: Pharmacist activist criticizes upcoming CVS split
Wall Street Analysts Forecast Growth
Several equities research analysts have commented on the stock. Evercore reaffirmed an “outperform” rating on shares of CVS Health in a report on Wednesday, November 4th. Royal Bank Of Canada cut their target price on shares of CVS Health from $113.00 to $108.00 and set an “outperform” rating for the company in a research report on Monday, November 16th. Argus lifted their target price on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research note on Wednesday, August 19th. Barclays lowered their price target on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating on the stock in a research report on Thursday, November 5th. Finally, Wells Fargo & Company lowered their price target on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a research report on Thursday, November 12th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $107.33.
Check Out Our Latest Analysis on CVS
Insider Buying and Selling at CVS Health
In related news, EVP Prem Shah purchased 23,855 shares of the firm’s stock in a transaction dated Friday, November 6th. The shares were purchased at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This represents a 36.89% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.85% of the stock is currently owned by corporate insiders.
CVS Health Price Performance
CVS Health stock opened at $80.83 on Friday. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The business has a fifty day moving average price of $88.42 and a 200-day moving average price of $89.29. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. The firm has a market capitalization of $103.42 billion, a P/E ratio of 9.41, a PEG ratio of 0.77 and a beta of 0.58.
CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The company had revenue of $108.40 billion during the quarter, compared to analysts’ expectations of $104.72 billion. During the same period in the previous year, the business earned $1.60 earnings per share. The firm’s quarterly revenue was up 5.4% compared to the same quarter last year. As a group, equities research analysts forecast that CVS Health Corporation will post 8.26 EPS for the current year.
CVS Health Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s payout ratio is presently 30.97%.
CVS Health Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Featured Articles
- Five stocks we like better than CVS Health
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
